PDA

View Full Version : Medical Articles and Abstracts


Pages : 1 2 3 [4] 5

  1. Hb content-based transfusion policy successfully reduces RBC units transfused
  2. Transfusion Trigger?
  3. Perioperative Blood Transfusion Is Predictive of Poststernotomy Surgical Site Infect
  4. Effect of flow chart on blood transfusions in TJR prospective before and after
  5. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron p
  6. Survival after transfusion as assessed in a large multistate US cohort
  7. Trauma-care revolution among benefits touted as blood substitute enters critical phas
  8. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban
  9. Epoetin Use for Anemia in Chronic Renal Failure
  10. Epoetin Use for Anemia in Oncology
  11. Recombinant factor VIIa prophylaxis in patient severe congenital factor VII deficienc
  12. Successful CABG in a patient with paroxysmal nocturnal hemoglobinuria
  13. Effective and safe use of recombinant factor VIIa in elderly mild haemophilia A
  14. Predictive value of megakaryocytic and erythroid colony formation/platelet function
  15. predictive value of megakaryocytic and erythroid colony formation/platelet function
  16. Effective and safe use of recombinant factor VIIa in elderly mild haemophilia A
  17. Effective and safe use of recombinant factor VIIa in elderly mild haemophilia
  18. Cardiac reoperation by Carpentier bicaval femoral venous cannula: GATA experience
  19. Thalidomide for treatment of severe intestinal bleeding
  20. Thalidomide for treatment of severe intestinal bleeding
  21. Clopidogrel-Plavix does not increase bleeding and allogenic blood transfusion in CABG
  22. Clopidogrel does not increase bleeding and allogenic blood transfusion in CABG
  23. Clopidogrel-Plavix does not increase bleeding and allogenic blood transfusion in CABG
  24. Selection of Abstracts on Treating Anemia
  25. Recombinant Factor VIIa for severe surgical liver bleeding in 5 month old baby
  26. Blood Transfusion Poses CJD Risk - News From Lancet
  27. Recombinant FVIIa in the management of uncontrolled hemorrhage.
  28. Patients with impending abdominal compartment syndrome do not respond to early volume
  29. Factors involved in gastrointestinal bleeding in advanced cancer patients followed at
  30. Validation of a transfusion prediction model in head and neck cancer surgery
  31. Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery d
  32. Does manual removal of the placenta affect operative blood loss during cesarean sect
  33. Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after
  34. Autoantibody formation after alloimmunization: are blood transfusions a risk factor f
  35. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood prod
  36. Clinical factors associated with an increased risk of perioperative blood transfusion
  37. Operative blood loss and use of blood products after laparoscopic and conventional op
  38. Does blood transfusion increase risk of postoperative complications?
  39. Primary OPCAB as a Strategy for Acute Coronary Syndrome and Acute Myocardial Infarcti
  40. Risks of blood transfusion
  41. Blood conservation in the intensive care unit
  42. Transfusion medicine : support of patients undergoing cardiac surgery
  43. he effect of aspirin on blood loss and transfusion requirements in patients with femo
  44. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in pati
  45. Blood conservation in primary total hip arthroplasty
  46. Blood conservation strategies in Jehovah's Witness patients undergoing complex aortic
  47. Cardiac-effect of preoperative antiplatelet/anticoagulant prophylaxis postop bleeding
  48. Surgery without blood - Shander
  49. Predictors of transfusion requirements for cardiac surgical procedure
  50. Acute normovolemic hemodilution and intraoperative cell salvage in aortic surgery
  51. A mathematical model of cell salvage efficiency
  52. Blood-transfusion requirements and blood salvage in donors/live donor liver transplan
  53. Blood management after bilateral total knee arthroplasty
  54. Bacterial reduction by cell salvage washing and leukocyte depletion filtration
  55. A comparison of red cell recovery between two different methods of red cell washing
  56. blood salvage during cesarean delivery in a patient with beta thalassemia intermedia
  57. Intraoperative Cell Salvage With Autotransfusion In Patients Undergoing Radical Retro
  58. Study of five cell salvage machines in coronary artery surgery
  59. A meta-analysis of the effectiveness of cell salvage to minimize perioperative transf
  60. Impact of red cell salvage on transfusion requirements during elective AAA
  61. Cell salvage for minimising perioperative allogeneic blood transfusion
  62. preoperative antiplatelet/anticoagulant prophylaxis on postoperative blood loss in CV
  63. Surgery without blood
  64. The CRIT Study: Anemia and blood transfusion in the critically ill
  65. A randomized trial of aprotinin (Trasylol) on blood loss, blood product requirement..
  66. Cell salvage for minimising perioperative allogeneic blood transfusion
  67. Quantifying risk of transfusion in children undergoing spine surgery.
  68. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion total joint
  69. Autotransfusion of shed mediastinal blood: a risk factor for mediastinitis after CABG
  70. [Intensive care patients need blood transfusion--with limits. Risks versus benefits
  71. RBC in Liver Transplantation: influence/outcome, predict/requirements, reducing
  72. Efficacy of intraoperative blood collection and reinfusion in revision total hip
  73. [Modern management of bleeding disorders and haemorrhage in otorhinolaryngology]
  74. Blood exposures and hepatitis C virus infections among emergency responders
  75. [Evidence-based management of chemotherapy related thrombocytopenia]
  76. Factors involved in gastrointestinal bleeding in advanced cancer patients [at home]
  77. Stents versus balloon angioplasty in non-acute coronary artery disease
  78. Does manual removal of the placenta affect operative blood loss during cesarean?
  79. Lovenox and retroperitoneal bleed
  80. Hemodialysis - Recombinant EPO therapy increases erythrocyte expression
  81. Online Presentation - Challange of Transfusion Alternatives - Actual and Prospective
  82. Pharmacotherapy of essential thrombocythaemia: economic considerations
  83. Coagulation monitoring and management of anticoagulation during cardiac assist device
  84. An Improved Definition of Immune Heparin-Induced Thrombocytopenia
  85. Oral vs Intravenous Vitamin K1 in Patients With Excessive Anticoagulation
  86. Markers of Coagulation and Angiogenesis in Cancer-Associated Venous Thromboembolism
  87. Defective RNA ribose synthesis in fibroblasts from patients with TRMA
  88. Recombinant humanized anti-IL-2 receptor antibody response in aplastic anemia
  89. Quantification of PRV-1 mRNA distinguishes PV secondary erythrocytosis
  90. New JAMA - Anemia and Heart Failure
  91. Volume 1 Number 11 November SABM Abstracts 003
  92. Quality of intraoperative autologous blood withdrawal used for retransfusion/ CABG
  93. Blood conservation strategies in Jehovah's Witness patient
  94. A method of blood conservation in Jehovah's witnesses
  95. impact of standard fluid management on the effectiveness of ANH in AAA
  96. Are tourniquets and drains really required in primary total knee?
  97. Anaphylactic transfusion reactions
  98. Risks of transfusion-transmitted infections: 2003
  99. Erythropoietin to treat head and neck cancer patients with anaemia
  100. Occam's razor; anaemia and orthostatic hypotension
  101. Hemoglobin F in primary myelofibrosis and in myelodysplasia
  102. Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis
  103. Duration/morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children
  104. Pharmacoeconomic considerations in the health system management of anaemia in patient
  105. Blood Use in Patients Undergoing Coronary Artery Bypass Surgery
  106. Emerging Infections, Transfusion Safety, and Epidemiology
  107. Transmission of West Nile Virus through Blood Transfusion in the United States - 2000
  108. A comparison of bleeding and transfusion in CABG & OPCAB
  109. Perioperative Anemia Requires Careful Evaluation and Treatment
  110. Anemia Not Directly Linked to Mortality After Acute MI
  111. Untreated Anemia Associated/increased Risk Of Mortality/morbidity
  112. Monitoring blood transfusion in patients undergoing coronary artery bypass grafting:
  113. Antiapoptotic effect of coagulation factor VIIa
  114. Detection of West Nile Virus in Blood Donations --- United States, 2003
  115. Computerized quality assurance of decisions to transfuse blood to the critically ill
  116. etiology and the effect of immunosuppressive therapy on erythropoiesis
  117. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based
  118. Suboptimal Erythropoietic Response to Hypoxemia in Idiopathic Pulmonary Fibrosis
  119. Anemia and Blood Transfusion in Trauma Patients Admitted to the Intensive Care Unit
  120. Lupus anticoagulants in children
  121. Inherited platelet disorders
  122. Long-term Use of Hydroxyurea for Sickle Cell Anemia—Reply
  123. Long-term Use of Hydroxyurea for Sickle Cell Anemia
  124. The Effects of EPO Given Immediately After Delivery
  125. SABM Literature Abstracts - July 2003
  126. Allogeneic blood transfusion increases the risk of postoperative bacterial infection
  127. WBC-containing allogeneic blood transfusion and mortality
  128. Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery
  129. Uses and sources of data on long-term survival after blood transfusion
  130. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion
  131. Use of off-pump and on-pump CABG strategies in current clinical practice - Outcomes
  132. The efficacy and safety of aprotinin for hemostasis during intracranial surgery
  133. The management of perioperative bleeding
  134. Identification of risk factors for allogenic transfusion in cardiac surgery
  135. Factors for prolonged length of stay after elective hepatectomy
  136. Effects of enoxaparin vs unfractionated heparin on bleeding in CABG
  137. Efficacy of a single, weekly dose of recombinant EPO in myelodysplastic syndromes
  138. Ethical and medicolegal considerations in the obstetric care of a Jehovah's Witness
  139. Acute normovolemic hemodilution combined with inhibition of fibrinolysis and Cell Sav
  140. Anemia and erythropoietin in critically ill patients
  141. Influence of Allogeneic Blood Transfusion on Clinical Outcome during Radiotherapy
  142. Severe immune haemolysis in a group A recipient of a group O red blood cell unit
  143. Patient safety and blood transfusion: New solutions
  144. Transmission of HIV Type 1 through Blood Transfusion from an Antibody-Negative/p24
  145. Infectious risks of blood transfusion
  146. Fatal west nile virus meningoencephalitis associated / blood transfusion CV Surgery
  147. Myocardial ischaemia precipitated by acute normovolaemic haemodilution
  148. Influence of transfusions on perioperative and long-term outcome
  149. Peri-operative use of EPO
  150. Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood trans
  151. Blood conservation in primary total hip arthroplasty
  152. Rising blood prices prompt hospitals to find cost-effective alternatives
  153. Attachment Pediatric Abstracts - August 2003
  154. Diamond-Blackfan anaemia response to cyclosporin-A therapy six years after diagnosis
  155. Estimated risk of transmission of the West Nile virus through blood
  156. West Nile virus infection transmitted by blood transfusion
  157. West Nile virus in blood: stability, distribution, and susceptibility PEN110
  158. West Nile virus and the safety of plasma derivatives
  159. Haemoglobin concentration and prognosis in new cases of heart failure
  160. Open versus laparoscopic splenectomy for idiopathic thrombocytopenic purpura
  161. Aortic Stenosis, von Willebrand Factor, and Bleeding
  162. Acquired von Willebrand Syndrome in Aortic Stenosis
  163. Valproate induces reversible factor XIII deficiency with risk of perioperative bleed
  164. Erythropoietin Given Immediately After Delivery to Women With Anaemia
  165. Anemia, Blood Transfusion, and Erythropoietin in the Critically Ill
  166. Haemoglobin concentration and prognosis in new cases of heart failure
  167. Thrombopoietin concentrations in peripheral blood
  168. Red Cell Transfusion "Trigger": A Review
  169. Correlation Between Perioperative Blood Transfusion and Prognosis of Patients
  170. Anticoagulant-Related Bleeding in Older Persons With Atrial Fibrillation .....
  171. Platelet activation is increased in peripheral arterial disease
  172. Pediatric Abstracts - May 2003
  173. Pediatric Abstracts - July 2003
  174. Emergency Management of Hemorrhagic Complications
  175. Gastroenterology - helicobacter pylori and von Willebrand - induce platelet ag
  176. Complementary role / limitations of hepatitis C virus antibody and nucleic acid tests
  177. Acute thrombocytopenia associated with eptifibatide therapy
  178. Preoperative administration of epoetin alfa to reduce transfusion requirements in TJ
  179. Reduction of transfusion rates in the surgical correction of sagittal synostosis
  180. acute normovolemic hemodilution to minimize allogeneic blood transfusion liver resect
  181. Transfusion Requirements...hepatectomy..living donor
  182. Acute normovolemic hemodilution in urologic surgery
  183. Effect of aprotinin on transfusion requirements in pediatric orthotopic liver transpl
  184. Off-pump redo coronary artery bypass grafting: technical aspects and early results
  185. Recombinant Factor VIIa for the Management of Pediatric Coagulopathic Diseases
  186. Oxygen Therapeutics in Trauma and Surgery
  187. The Risk of Death for Jehovah's Witnesses after Major Trauma
  188. Resuscitation/Hemoglobin-Based Oxygen Carrier/Uncontrolled Periop Hemorrhage
  189. Allogeneic Blood Transfusion Increases the Risk of Postoperative Bacterial Infection
  190. Blood Transfusion, Independent of Shock Severity Associated/Worse Outcome in Trauma
  191. Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platele
  192. Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8
  193. [Pernicious anemia and malignancy]
  194. Late-onset X-linked sideroblastic anemia following hemodialysis
  195. Differences in the perception of blood transfusion risk between laypeople and MDs
  196. Prevalence of transfusion-transmissible viral infections in first-time US donors Prevalence of tr
  197. Frequency of HBV DNA detection in US blood donors testing positive for...anti-HBc
  198. Infusion of donor-derived hematopoietic stem cells in organ transplantation: clinical
  199. Thrombopoietin increases platelet adhesion under flow and decreases rolling
  200. Aprotinin restores the adhesive capacity of dysfunctional platelets
  201. Pathologic Quiz Case: A 2-Year-Old Boy With a Hereditary Bleeding Disorder
  202. An update on the pathogenesis and management of acquired thrombotic thrombocytopenic
  203. Potential new therapeutics for Waldenstrom's macroglobulinemia - Thalidomide
  204. Novel therapies in multiple myeloma - CC-5013 and bortezomib
  205. Effect of a National Disaster on Blood Supply and Safety
  206. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia
  207. Recovery from refractory ITP in three patients treated with etanercept
  208. Pharmacologic Tools for Blood Avoidance in Cadiac Surgery
  209. Blood Avoidance Mechanicals for Cadiac Surgery
  210. Blood Avoidance Algorithm for Cadiac Surgery
  211. Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies
  212. New Guidelines for Occupational Exposure to Bloodborne Viruses
  213. Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood
  214. L-arginine, the Substrate for NO, Is...Low in Acute Vasoocclusive Sickle C Crisis
  215. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children
  216. Perioperative Management of Patients Receiving Oral Anticoagulants
  217. Prevention and Control of Iron Deficiency Anemia Amongst Young Children
  218. The Outpatient Bleeding Risk Index
  219. May Pediatric Abstracts
  220. The harmonic scalpel and surgery of the thyroid gland
  221. Off-label use of recombinant factor VIIa in patients following bone marrow transplant
  222. The evidence behind inhibitor treatment with recombinant factor VIIa
  223. Recombinant factor VIIa to treat coagulation disturbances in pediatric patients
  224. Recombinant factor VIIa in children with inherited platelet function disorders
  225. Future generations of red blood cell substitutes (Chang - McGill)
  226. Benefit and risk perceptions in transfusion medicine: blood and blood substitutes
  227. Intraoperative Detection of Traumatic Coagulopathy... Activated Coagulation Time
  228. DDAVP normalized the bleeding time... congenital platelet TxA2 receptor
  229. Emerging infectious disease issues in blood safety
  230. Rethinking blood shield statutes
  231. Transfusion of blood components and postoperative infection in cardiac surgery
  232. Association of bacterial infection and red blood cell transfusion after CABS
  233. Blood transfusions correlate with infections in trauma patients
  234. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates
  235. Intraoperative Detection of Traumatic Coagulopathy Using the Activated Coagulation Ti
  236. Future generations of red blood cell substitutes
  237. Current status of blood substitute research: towards a new paradigm
  238. Benefit and risk perceptions in transfusion medicine: blood and blood substitutes
  239. SARS- Travelers from Canada
  240. Early primary immune response against erythrocytes: a case report
  241. Multivariate predictors of blood product use in cardiac surgery
  242. Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction
  243. Seven Ways to Control Postpartum Hemorrhage
  244. Serious Hazards of Transfusion (SHOT) 99-00
  245. Serious Hazards of Transfusion SHOT - 98-99
  246. Non-Infectious Serious Hazards of Transfusion
  247. Deleterious Effects of Blood Transfusions
  248. BMJ articles of interest.
  249. Pediatric Abstracts - April 2003
  250. Bloodless medicine and surgery in the OR and beyond